GEN Exclusives

More »

GEN News Highlights

More »
Apr 7, 2014

Rockland Invests $1M in New Award for Young Investigators

  • Rockland Immunochemicals is awarding $100,000/year in total to 25 young scientists, including grad students and postdocs, over the next 10 years to help them establish themselves in the areas of oncology, nuclear signaling, developmental biology, epigenetics, immunology, microbiology, neuroscience, signal transduction, or stem cell technology.

    Recipients of the Joy Cappel 2014 Young Investigator Award—named after Joy Cappel, who was Rockland's president and CEO for over 30 years—will get access to Rockland’s antibody development team and products as well as the chance to work with Rockland scientists toward common goals.

    Successful award winners will also get to develop and characterize an antibody that meets their research objectives and includes antigen design, peptide synthesis, antibody production, antibody purification, and antibody analysis by ELISA and/or Western blotting or similar immunoassay. In addition, some scientists will also have the opportunity to work with professionals from Rockland to initiate polyclonal antibody development activities.

    The first three winners of the award are:

    • Parham Ramezani-Rad of Sanford-Burnham Medical Research Institute
    • Christopher Oberley, Ph.D., of the University of Wisconsin, Madison
    • Feng He, Ph.D., of the University of California, San Diego

    "The tools and capabilities that we will provide to these young investigators will support their research and develop key project management and partnering skills that will advance their careers," Rockland's COO Richard Smith said in a statement. "We expect great things from the joint efforts of our scientists and these promising researchers."



Related content

Jobs

GEN Jobs powered by HireLifeScience.com connects you directly to employers in pharma, biotech, and the life sciences. View 40 to 50 fresh job postings daily or search for employment opportunities including those in R&D, clinical research, QA/QC, biomanufacturing, and regulatory affairs.
 Searching...
More »

GEN Poll

More » Poll Results »

Should “Special K” Get Special Treatment?

In the near term, what is the best way to use ketamine in treating depression?